首页|临床药师参与中枢神经系统毛霉菌感染治疗的实践及思考

临床药师参与中枢神经系统毛霉菌感染治疗的实践及思考

扫码查看
中枢神经系统毛霉菌感染是一种病情凶险的颅内感染性疾病,病死率达到50%以上。本文介绍了2例中枢神经系统毛霉菌感染危重病例,并从全身治疗药物的选择、局部治疗用药的选择及两性霉素B的用法用量、治疗疗程与序贯治疗、输注过程中的监护、发生不良反应后的对策等方面进行总结与分析,以期为临床用药提供参考。
Practice and experience of clinical pharmacists participating in the treatment of mucormycosis infection in central nervous system
Mucormycosis infection of the central nervous system is a dangerous intracranial infectious disease with a mor-tality rate of over 50%.In this paper,two cases of severe Mucormycosis infection in the central nervous system were intro-duced.The selection of systemic and local drugs,the usage and dosage of amphotericin B,the course of treatment and sequen-tial treatment,the monitoring and the countermeasures after adverse reactions caused by the application of amphotericin B were summarized and analyzed to a provide reference for clinicians and pharmacists.

mucormycosis infectionamphotericin Bclinical pharmacist

庄伟、齐晓涟、高冉、张婧、杨毅恒、褚燕琦、董宪喆、张兰

展开 >

首都医科大学宣武医院 药学部,北京 100053

首都医科大学宣武医院 神经内科,北京 100053

北京大学第三医院 药剂科,北京 100191

毛霉菌感染 两性霉素B 临床药师

2024

临床药物治疗杂志
北京药学会

临床药物治疗杂志

CSTPCD
影响因子:1.07
ISSN:1672-3384
年,卷(期):2024.22(1)
  • 11